AOTMiT: Big changes in the chemotherapy catalog?

The agenda includes:

1 Prepare a position paper on reimbursement of Kinpeygo (budesonide) technology under the drug program "Treatment of patients with primary IgA nephropathy (ICD-10: N02.8)";

2 Prepare an opinion on the draft health policy program of the local government unit "Regional Health Program - Cardiac Rehabilitation module";

3 Prepare an opinion on the transfer of cetuximab from the drug program B.52. "Treatment of squamous cell carcinoma of the organs of the head and neck" to the catalog of reimbursed drugs in chemotherapy;

4 Prepare an opinion on the transfer of cetuximab from drug progra...